Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/25 16:54 | 7/28/25 | GILD | Health | BioPrd | Biological Products, (No Diag | O'Day Daniel Patrick | CA | DO | CB,CEO | 4 | S.d | -3,348 | 82.82 | 0 | -40 | 626 | D | |||||||||||||||
7/28/25 17:10 | 7/25/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Telman Deborah H | CA | O | EVP,Corp | 2 | M.d | 0 | 0.00 | 0 | 10 | 31 | 43 | D | ||||||||||||||
7/16/25 17:45 | 7/15/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 5 | S.d | -5,340 | 84.98 | 0 | -63 | 123 | D | |||||||||||||||
7/16/25 17:41 | 7/15/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Dickinson Andrew D | CA | O | CFO | 4 | S.d | -803 | 71.69 | 0 | -11 | 168 | D | |||||||||||||||
7/15/25 15:59 | 7/14/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Bluestone Jeffrey | CA | D | 2 | M.d | 886 | 88.60 | 0 | 10 | 9 | D | ||||||||||||||||
7/15/25 15:59 | 7/14/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Bluestone Jeffrey | CA | D | 2 | S.d | -886 | 88.60 | 0 | -10 | 9 | D | ||||||||||||||||
6/11/25 19:10 | 6/10/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Wilfong Diane E. | CA | O | Interim | 1 | M.d | 0 | 0.00 | 0 | 1 | 2 | 46 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |